What one share of Filana Therapeutics holds
Filana Therapeutics, Inc. (formerly Cassava Sciences, Inc.) is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to develop transformative medicines to improve the lives of patients with central nervous system (CNS) disorders, such as Tuberous Sclerosis Complex (TSC)-related epilepsy and other diseases associated with dysregulation or overexpression of filamin A.
Filana Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-03-31; the balance sheet is as of 2026-03-31.
| Profit | −$1.61 |
|---|---|
| Cash and investments | $1.79 |
| Book value | $1.41 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $3.32 | −$0.56 | — | — | — | $17.49 |
| 2010 | $2.76 | −$1.97 | — | — | — | $5.37 |
| 2011 | $1.82 | −$0.41 | — | — | — | $6.95 |
| 2012 | $1.70 | −$0.56 | — | — | — | $2.03 |
| 2013 | $6.37 | $4.88 | — | — | — | $7.43 |
| 2014 | — | −$1.92 | $0.01 | −$1.49 | — | $6.13 |
| 2015 | — | −$2.16 | $0.03 | −$1.41 | — | $4.49 |
| 2016 | — | −$2.28 | $0.01 | −$1.89 | — | $2.83 |
| 2017 | — | −$1.82 | — | — | — | $1.47 |
| 2018 | — | −$0.61 | — | — | — | $1.14 |
| 2019 | — | −$0.27 | $0.00 | −$0.15 | — | $1.01 |
| 2020 | — | −$0.24 | — | — | — | $2.62 |
| 2021 | — | −$0.82 | $0.56 | −$1.33 | — | $6.35 |
| 2022 | — | −$1.90 | $0.07 | −$2.00 | — | $5.45 |
| 2023 | — | −$2.32 | $0.01 | −$1.97 | — | $3.25 |
| 2024 | — | −$1.46 | $0.00 | −$2.51 | — | $3.02 |
| 2025 | — | −$1.88 | $0.01 | −$0.68 | — | $1.54 |
Common questions about Filana Therapeutics
How much does one share of Filana Therapeutics earn?
Over the last 12 months, Filana Therapeutics lost $1.61 for each share.
Does Filana Therapeutics pay a dividend?
Filana Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Filana Therapeutics’s book value per share?
Filana Therapeutics’s book value is $1.41 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of March 31, 2026.
How much cash and debt does each share of Filana Therapeutics have?
Each share of Filana Therapeutics has $1.79 of cash and investments, as of March 31, 2026.
Has Filana Therapeutics bought back shares?
Filana Therapeutics’s share count rose about 680% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.